Sunday August 9, 2020

Drugs firm examined by regulator after ‘shocking’ safety breaches

The Health Products Regulatory Authority (HPRA) said it was concerned and was “following up with" drug maker Astellas

Susan Mitchell

Deputy Editor and Health Editor

@susmitchellsbp
2nd July, 2017

Ireland’s medicines regulator is assessing the possible implications for Ireland after the drugmaker Astellas was accused of “shocking” breaches of guidelines that “raised serious concerns with regard to patient safety” in Britain.

In a statement to this newspaper last week, the Health Products Regulatory Authority (HPRA) said it was concerned and was “following up with Astellas as regards any possible implications for the advertising and promotion of the company’s...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

2 Yearly

€315

€248

Unlimited Access for 2 Years

This product does not auto-renew

Team Pass

Get a Business Account for you and your team

Share this post

Related Stories

Irish doctors will not use the term ‘fully reversible’ in future, following a change in Britain’s NHS guidance on hormone treatment for transgender children

Aaron Rogan | 15 hours ago

The founder of the expert group EndCoronavirus says New Zealand’s zero tolerance model is the only option against the virus

Rachel Lavin | 15 hours ago

Paul Reid explains how being thrown in at the deep end and dealing with the coronavirus pandemic has altered his approach to managing the health service

Daniel Murray | 15 hours ago